Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-004-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Data waiving:
- other justification
- Justification for data waiving:
- other:
Cross-reference
- Reason / purpose for cross-reference:
- data waiving: supporting information
Reference
- Endpoint:
- short-term repeated dose toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April - May 1993
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study without detailed documentation
- Justification for type of information:
- Please see Analogue Approach
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 410 (Repeated Dose Dermal Toxicity: 21/28-Day Study)
- GLP compliance:
- yes
- Clinical signs:
- no effects observed
- Dermal irritation:
- no effects observed
- Mortality:
- no mortality observed
- Description (incidence):
- No death ocurred during the study in any of the 3 groups.
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- Body weight gain was similar in all 3 groups in the 28 days of treatment.
- Food consumption and compound intake (if feeding study):
- no effects observed
- Description (incidence and severity):
- The food consumption was similar in all 3 groups.
- Ophthalmological findings:
- not specified
- Haematological findings:
- no effects observed
- Description (incidence and severity):
- There was a significant difference in the sodium and total protein in the satellite group and of calcium in the males. The effects are not considered as caused by the treatment.
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Description (incidence and severity):
- The weight of organs did not show any significant variations in relation to the treatment.
- Gross pathological findings:
- no effects observed
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Details on results:
- CLINICAL SIGNS AND MORTALITY
No deaths occurred during the study in any of the 3 groups (treated - satellite - control).
No clinical signs were observed during the experimental observation period in all 3 groups. In particular no erythema and/or oedema was observed in the test group.
BODY WEIGHT AND WEIGHT GAIN
Body weight gain was similar in all 3 groups.
FOOD CONSUMPTION
Food consumption was similar in all 3 groups.
HAEMATOLOGY
No significant differences in all 3 groups.
CLINICAL CHEMISTRY
Significant differences were measured in the sodium and total protein of the satellite group. These effects are not considered as caused as relevant.
ORGAN WEIGHTS
The weight of organs did no show any significant variations in relation to the treatment.
GROSS PATHOLOGY
At the ante-mortem examination in all animals no pathological symptoms were observed.
No macroscopic abnormalities related to the treatment were seen at necropsy.
Minor anomalies were observed in 1/5 males and 2/5 females of the test group, 2/5 male and 2/5 females in the control group and 2/5 males and 2/5 females in the satellite group. These minor findings were gastric meteorism, presence of granular tissue on stomach wall, liverworth steatosis, kidney cyst, ovary cyst and spleen iperplasy of white pulp. These changes don't have any toxicological relevance. - Dose descriptor:
- NOAEL
- Effect level:
- 10 other: mL/kg bw/day (nominal)
- Based on:
- test mat.
- Remarks:
- no remarks
- Sex:
- male/female
- Basis for effect level:
- other: no effects
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Dose descriptor:
- NOEL
- Effect level:
- 10 other: mL/kg bw/day (nominal)
- Based on:
- test mat.
- Remarks:
- no remarks
- Sex:
- male/female
- Basis for effect level:
- other: no effects
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Remarks:
- no remarks
- Sex:
- male/female
- Basis for effect level:
- other: no effects
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Key result
- Critical effects observed:
- no
- Conclusions:
- In experimental conditions, on the basis of a total evaluation of the results obtained, the test material Butanedioic acid, 2,3-dihydroxy-di-C14-C15 alkyl esters did not cause any local or systemic toxicity. The NOAEL was determined to be 10 mL/kg bw/day (1000 mg/kg bw/d).
- Executive summary:
The study of subacute dermal toxicity (28 days) was performed on a group of 30 rabbits (20 treated and 10 controls).
The test material, Butanedioic acid, 2,3-dihydroxy-di-C14-C15 alkyl esters, was administered for 4 weeks (5 days out of 7) at daily dose of 10 mL/kg bw (1000 mg/kg bw/d) by dermal application. The test material was administered in sesam oil to 20 animals, while the control group (10 animals) were treated with sesame seed oil.
The animals were sacrificed at the end of treatment, on the 28th days (treated and control groups) with the exception of 10 rabbits which had been treated with the test material, they were kept under observation for another 2 weeks after the end of treatment (satellite group).
During the study animals were observed daily for possible toxicity symptoms. These observations included: evaluation of local reaction in the application aria, evaluation of organ functions, evaluation of the tegumentary apparatus conditions, evaluation of possible variations in somatomotor activity and sensorium conditions, evaluation of mucosae conditions. Animals body weight and food consumed were recorded weekly. At the end of the study a blood taking from heart in all animals was executed in order to evaluate the hematological and hematochemical parameters in the three groups (treated and controls), then an autopsy was performed.
The results obtained from the study can be summarized as follows: No case of mortality and no pathological symptoms were observed in the animals treated and in the control animals, in particular no phenomena of erythema or oedema was observed in the area where the test material was applied.
At the autopsy no pathological anomalie were observed. The weight of the organs showed no significant differences between the 3 groups. The hematological and hematochemical examinations, conducted at the end of the study did not show any significant differences between the groups.
In experimental conditions, on the basis of a total evaluation of the results obtained, the test material Butanedioic acid, 2,3-dihydroxy-di-C14-C15 alkyl esters did not cause any local or general toxicity.
Data source
Materials and methods
Results and discussion
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
